NCT01471821View on ClinicalTrials.gov

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
HIV Infection
Interventions
DRUG

antiretroviral treatment

antiretroviral treatment

Trial Locations (2)

28046

Hospital Universitario La Paz, Madrid

08036

Hospital Clínic i Provincial Barcelona, Barcelona

All Listed Sponsors
lead

Juan A. Arnaiz

OTHER

NCT01471821 - Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression | Biotech Hunter | Biotech Hunter